相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Telomere Stress Potentiates STING-Dependent Anti-tumor Immunity
Ilgen Mender et al.
CANCER CELL (2020)
In perspective: An update on telomere targeting in cancer
Eric T. Sugarman et al.
MOLECULAR CARCINOGENESIS (2019)
BIBR1532, a Selective Telomerase Inhibitor, Enhances Radiosensitivity of Non-Small Cell Lung Cancer Through Increasing Telomere Dysfunction and ATM/CHK1 Inhibition
Xiaofeng Ding et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2019)
Activation of the Receptor Tyrosine Kinase AXL Regulates the Immune Microenvironment in Glioblastoma
Hirokazu Sadahiro et al.
CANCER RESEARCH (2018)
Induction of Telomere Dysfunction Prolongs Disease Control of Therapy-Resistant Melanoma
Gao Zhang et al.
CLINICAL CANCER RESEARCH (2018)
Mutant ATRX: uncovering a new therapeutic target for glioma
Santiago Haase et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2018)
Inhibition of Rb and mTOR signaling associates with synergistic anticancer effect of palbociclib and erlotinib in glioblastoma cells
Songlin Liu et al.
INVESTIGATIONAL NEW DRUGS (2018)
Induced Telomere Damage to Treat Telomerase Expressing Therapy-Resistant Pediatric Brain Tumors
Satarupa Sengupta et al.
MOLECULAR CANCER THERAPEUTICS (2018)
New Directions in the Treatment of Glioblastoma
Zachary J. Reitman et al.
SEMINARS IN NEUROLOGY (2018)
Telomerase-Mediated Strategy for Overcoming Non-Small Cell Lung Cancer Targeted Therapy and Chemotherapy Resistance
Igen Mender et al.
NEOPLASIA (2018)
Disruption of the β1L Isoform of GABP Reverses Glioblastoma Replicative Immortality in a TERT Promoter Mutation-Dependent Manner
Andrew Mancini et al.
CANCER CELL (2018)
Systematic analysis of telomere length and somatic alterations in 31 cancer types
Floris P. Barthel et al.
NATURE GENETICS (2017)
CBTRUS Statistical Report: Primary Brain and Other Central Nervous System Tumors Diagnosed in the United States in 2009-2013
Quinn T. Ostrom et al.
NEURO-ONCOLOGY (2016)
The transcription factor GABP selectively binds and activates the mutant TERT promoter in cancer
Robert J. A. Bell et al.
SCIENCE (2015)
HTSeq-a Python framework to work with high-throughput sequencing data
Simon Anders et al.
BIOINFORMATICS (2015)
Induction of Telomere Dysfunction Mediated by the Telomerase Substrate Precursor 6-Thio-2'-Deoxyguanosine
Ilgen Mender et al.
CANCER DISCOVERY (2015)
Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2
Michael I. Love et al.
GENOME BIOLOGY (2014)
STAR: ultrafast universal RNA-seq aligner
Alexander Dobin et al.
BIOINFORMATICS (2013)
Recombinant anti-podoplanin (NZ-1) immunotoxin for the treatment of malignant brain tumors
Vidyalakshmi Chandramohan et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Mibefradil, a novel therapy for glioblastoma multiforme: cell cycle synchronization and interlaced therapy in a murine model
Stephen T. Keir et al.
JOURNAL OF NEURO-ONCOLOGY (2013)
A Modified HSP70 Inhibitor Shows Broad Activity as an Anticancer Agent
Gregor M. Balaburski et al.
MOLECULAR CANCER RESEARCH (2013)
TERT promoter mutations occur frequently in gliomas and a subset of tumors derived from cells with low rates of self-renewal
Patrick J. Killela et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cellular Redox Modulator, ortho Mn(III) meso-tetrakis(N-n-Hexylpyridinium-2-yl)porphyrin, MnTnHex-2-PyP5+ in the Treatment of Brain Tumors
Stephen T. Keir et al.
Anti-Cancer Agents in Medicinal Chemistry (2012)
PDGF and PDGF receptors in glioma
Inga Nazarenko et al.
UPSALA JOURNAL OF MEDICAL SCIENCES (2012)
The Sequence Alignment/Map format and SAMtools
Heng Li et al.
BIOINFORMATICS (2009)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Telomere measurement by quantitative PCR
RM Cawthon
NUCLEIC ACIDS RESEARCH (2002)
Therapeutic activity of 7-[(2-trimethylsilyl)ethyl)]-20 (S)-camptothecin against central nervous system tumor-derived xenografts in athymic mice
ST Keir et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2001)